KIMS Raises ₹1500 Crore via QIP at ₹755/Share
KIMS raised approximately ₹1,500 crore through a Qualified Institutions Placement (QIP). The company allotted 1,98,67,549 equity shares at ₹755 per share. The QIP opened on June 16, 2026, and closed on June 19, 2026. This issuance increases the company's paid-up equity share capital.
The QIP is a substantial fundraising event that will increase the company's equity base and potentially fund significant future growth initiatives or debt reduction, thus having a high impact on the company's financial structure.
The company successfully raised a significant amount of capital through a QIP, which is generally viewed positively as it strengthens the company's financial position and provides funds for growth.
Krishna Institute of Medical Sciences Limited (KIMS) has successfully completed a Qualified Institutions Placement (QIP) of equity shares, raising approximately ₹15,000 million (₹1,500 crore). The Finance & Investment Committee approved the allotment of 1,98,67,549 equity shares at an issue price of ₹755 per share, with a premium of ₹753 per share. This issue price includes a discount of ₹16.73, representing 2.17% of the floor price.
The QIP opened on June 16, 2026, and closed on June 19, 2026. Following this allotment, the company's paid-up equity share capital has increased to ₹84,00,12,968, comprising 42,00,06,484 equity shares, from the previous ₹80,02,77,870 with 40,01,38,935 equity shares.
A list of allottees who received more than five percent of the equity shares offered in the issue has been provided, including International Finance Corporation (10.00%), SBI ELSS Tax Saver Fund (6.67%), HDFC Life Insurance Company Limited (6.67%), Polar Capital Funds PLC - Healthcare Opportunities Fund (6.65%), and ICICI Prudential Smallcap Fund (5.17%), among others.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.